- Home
- QH vs PTIX Comparison
QH vs PTIX Comparison
Compare QH & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QH
- PTIX
- Stock Information
- Founded
- QH 2012
- PTIX 1994
- Country
- QH China
- PTIX United States
- Employees
- QH N/A
- PTIX N/A
- Industry
- QH Business Services
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- QH Consumer Discretionary
- PTIX Health Care
- Exchange
- QH Nasdaq
- PTIX Nasdaq
- Market Cap
- QH 6.6M
- PTIX 6.3M
- IPO Year
- QH 2020
- PTIX 2016
- Fundamental
- Price
- QH $7.11
- PTIX $3.14
- Analyst Decision
- QH
- PTIX
- Analyst Count
- QH 0
- PTIX 0
- Target Price
- QH N/A
- PTIX N/A
- AVG Volume (30 Days)
- QH 671.9K
- PTIX 96.0K
- Earning Date
- QH 09-26-2025
- PTIX 11-13-2025
- Dividend Yield
- QH N/A
- PTIX N/A
- EPS Growth
- QH N/A
- PTIX N/A
- EPS
- QH 0.33
- PTIX N/A
- Revenue
- QH $357,118,848.00
- PTIX N/A
- Revenue This Year
- QH N/A
- PTIX N/A
- Revenue Next Year
- QH N/A
- PTIX N/A
- P/E Ratio
- QH $19.84
- PTIX N/A
- Revenue Growth
- QH N/A
- PTIX N/A
- 52 Week Low
- QH $3.93
- PTIX $2.25
- 52 Week High
- QH $169.07
- PTIX $15.26
- Technical
- Relative Strength Index (RSI)
- QH 56.78
- PTIX 43.53
- Support Level
- QH $5.70
- PTIX $2.97
- Resistance Level
- QH $7.96
- PTIX $3.26
- Average True Range (ATR)
- QH 1.45
- PTIX 0.22
- MACD
- QH -0.26
- PTIX -0.04
- Stochastic Oscillator
- QH 37.62
- PTIX 27.38
About QH Quhuo Limited American Depository Shares
Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.